Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
2.580
-0.010 (-0.39%)
Nov 21, 2024, 2:34 PM EST - Market open

Leap Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-64.59-81.41-54.6-40.59-27.51-32.9
Upgrade
Depreciation & Amortization
0.010.020.020.030.030.05
Upgrade
Other Amortization
---0.140.14-
Upgrade
Asset Writedown & Restructuring Costs
-29.58----
Upgrade
Stock-Based Compensation
5.215.135.183.692.573.73
Upgrade
Other Operating Activities
-0.510.431.010.57-0.190.89
Upgrade
Change in Accounts Payable
4.290.710.953.9-2.61.08
Upgrade
Change in Unearned Revenue
----1.51.5-
Upgrade
Change in Other Net Operating Assets
-0.291.8-1.75-1.40.150.25
Upgrade
Operating Cash Flow
-55.17-43.75-49.04-35.16-25.96-26.9
Upgrade
Capital Expenditures
--1.39----0.1
Upgrade
Sale of Property, Plant & Equipment
----0.030.02
Upgrade
Cash Acquisitions
-50.36----
Upgrade
Investing Cash Flow
-48.97--0.03-0.09
Upgrade
Issuance of Common Stock
40.03--98.2248.9215.25
Upgrade
Repurchase of Common Stock
--0----
Upgrade
Other Financing Activities
-2.95-0.03-0.21-0.18-1.91-0.44
Upgrade
Financing Cash Flow
37.08-0.03-0.2198.047414.82
Upgrade
Foreign Exchange Rate Adjustments
0.17-0.04-0.16-0.030.12-0.22
Upgrade
Net Cash Flow
-17.925.14-49.4262.8548.18-12.39
Upgrade
Free Cash Flow
-55.17-45.15-49.04-35.16-25.96-27
Upgrade
Free Cash Flow Margin
----2343.80%-1730.47%-
Upgrade
Free Cash Flow Per Share
-1.62-2.21-4.33-4.10-4.38-11.96
Upgrade
Cash Income Tax Paid
--2.3-1.1-0.1-0.3-0.8
Upgrade
Levered Free Cash Flow
-32.77-46.85-28.27-20.46-15.67-14.91
Upgrade
Unlevered Free Cash Flow
-32.77-46.85-28.24-20.44-15.65-14.9
Upgrade
Change in Net Working Capital
-5.08-3.11-0.76-0.840.9-2.25
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.